Skip to main navigation Skip to search Skip to main content

False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States

Research output: Contribution to journalArticlepeer-review

Abstract

Screening with hepatitis B surface antigen (HBsAg) is highly recommended for at-risk individuals. Mutations in the HBsAg can result in an inability to detect the virus during routine screening. We describe a hemodialysis patient found to have high levels of hepatitis B virus (HBV) DNA and HBV antibody but negative HBsAg on two routine assays.

Original languageEnglish (US)
Pages (from-to)820-822
Number of pages3
JournalClinical and Vaccine Immunology
Volume19
Issue number5
DOIs
StatePublished - May 2012

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Clinical Biochemistry
  • Microbiology (medical)

Fingerprint

Dive into the research topics of 'False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States'. Together they form a unique fingerprint.

Cite this